All Type of News
The Halal wind in the pharmaceutical industry
‘Do you know what halal is?’
As interests in ‘halal’ have been suddenly raised by the President’s recent visit to the Middle East, the domestic pharmaceutical industry has begun pay attention to the halal market as w...
The number of regular thyroid cancer patients has continuously increase while the one the surgical patients has decreased
It is known that although the number of patients treated for thyroid cancer increased, the number of patients received surgery for the disease decreased.
Based on the development of treatments over ‘thyroid cancer su...
The Supreme Court nullified the Viagra’s use patent, accepting dismissal of the Pfizer’s appeal
The Supreme Court made the final decision that the use patent of the impotency treatment ‘Viagra’ is invalid. Thus, generic companies have gotten away from damage suits.
The Second Special Department of the Supreme C...
Pharmaceutical personnel related to Novartis are actively transferringPeople in charge of the Novartis’s drug price are actively transferring their jobs. It is shown that new personnel recruitment and change of position have been frequently made d...
|
GSK, Green Cross and SK are ambitious to lead in the tetravalent influenza marketGSK announced on the 22nd that it would launch the domestically first tetravalent influenza vaccine ‘Fluarix Tetra.’ Green Cross and SK Chemicals are also expected to launch tet...
|
Will Hanmi reappear the success of its impotency drug, Palpal?Hanmi Pharm, which has recorded the success in the impotency treatment ‘Viagra’ generic market, has raised curiosity in the pharmaceutical industry if it would revive the succes...
|
Generics of the top lung cancer treatment will appear, decreasing the overall drug price down by 38% for the disease
As the patent of the most selling lung cancer treatment ‘Alimta(Lilly Korea)’ will expire on the 10th next month, generic products with the same substance are about make sales.
It seems that generics, having 38% chea...
GSK will launch the first tetravalent flu vaccine ‘Fluarix Tetra’
GSK announced that it would launch the first domestic tetravalent influenza vaccine ‘Fluarix Tetra’.
Fluatrix Tetra includes 2 types of virus type A (A/H1N1, A.H3N2) and 2 types of virus type B (B-Victoria, B-Yamagat...
The golden age of DDP-4 continuing high-speed growth along with its complexes
In the diabetes treatment market, DPP-4 is making high-speed growth. It is also observed that the switching is currently on procedure after launches of generics.
According to the Medipana News’s analysis result of ou...
Consecutive drug price reductions of hyperlipidemia treatments, setting the price competition
The price has been magnified from the competition among hyperlipidemia treatments as launches of new drug and the drug price reduction.
According to the recent official announcement of the Health and Welfare, the cei...
